WordNet

relating to or resembling an ape; "simian features"
an ape or monkey
any of a group of viruses including those that in humans cause upper respiratory infections or infectious pinkeye

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. アデノウイルス感染の疫学および臨床症状 epidemiology and clinical manifestations of adenovirus infection
2. アデノウイルスの病因およびベクター使用 adenovirus pathogenesis and vector applications
3. アデノウイルス感染の診断、治療、および予防 diagnosis treatment and prevention of adenovirus infection
4. 成人におけるウイルス性胃腸炎の疫学および病因 epidemiology and pathogenesis of viral gastroenteritis in adults
5. 小児および思春期における急性感染性咽頭炎の診断へのアプローチ approach to diagnosis of acute infectious pharyngitis in children and adolescents

Taxonomy proposal for Old World monkey adenoviruses: characterisation of several non-human, non-ape primate adenovirus lineages.

Pantó L1,2, Podgorski II1, Jánoska M1, Márkó O1, Harrach B3.
Archives of virology.Arch Virol.2015 Dec;160(12):3165-77. doi: 10.1007/s00705-015-2575-z. Epub 2015 Sep 14.
A species classification regarding Old World monkey adenoviruses is proposed. We determined the nucleotide sequences of PCR-amplified fragments from the genes of the IVa2, DNA-dependent DNA polymerase, penton base, and hexon proteins from every simian adenovirus (SAdV) serotype that originated from
PMID 26370792

Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase 1 clinical trial in healthy adults.

Green CA1, Scarselli E2, Voysey M3, Capone S2, Vitelli A2, Nicosia A2, Cortese R2, Thompson AJ1, Sande CS1, de Lara C4, Klenerman P4, Pollard AJ1.
BMJ open.BMJ Open.2015 Oct 28;5(10):e008748. doi: 10.1136/bmjopen-2015-008748.
INTRODUCTION: Respiratory syncytial virus (RSV) infection causes respiratory disease throughout life, with infants and the elderly at risk of severe disease and death. RSV001 is a phase 1 (first-in-man), open-label, dose-escalation, clinical trial of novel genetic viral-vectored vaccine candidates P
PMID 26510727

Combination recombinant simian or chimpanzee adenoviral vectors for vaccine development.

Cheng C1, Wang L2, Ko SY3, Kong WP4, Schmidt SD5, Gall JG6, Colloca S7, Seder RA8, Mascola JR9, Nabel GJ10.
Vaccine.Vaccine.2015 Oct 26. pii: S0264-410X(15)01438-3. doi: 10.1016/j.vaccine.2015.10.023. [Epub ahead of print]
Adenoviral vector-based vaccines are currently being developed for several infectious diseases and cancer therapy, but pre-exising seroprevalence to such vectors may prevent their use in broad human populations. In this study, we investigated the potential of low seroprevalence non-human primate rAd
PMID 26514419

In Vitro Antiviral Activity of Marine Sponges Collected Off Brazilian Coast(Pharmacognosy)

Protection against mucosal simian immunodeficiency virus SIV (mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting